ID   STS_HUMAN               Reviewed;         583 AA.
AC   P08842; B2RA47;
DT   01-NOV-1988, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1990, sequence version 2.
DT   10-MAY-2017, entry version 179.
DE   RecName: Full=Steryl-sulfatase;
DE            EC=3.1.6.2;
DE   AltName: Full=Arylsulfatase C;
DE            Short=ASC;
DE   AltName: Full=Steroid sulfatase;
DE   AltName: Full=Steryl-sulfate sulfohydrolase;
DE   Flags: Precursor;
GN   Name=STS; Synonyms=ARSC1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PARTIAL PROTEIN SEQUENCE, GLYCOSYLATION AT
RP   ASN-47 AND ASN-259, AND LACK OF GLYCOSYLATION AT ASN-333 AND ASN-459.
RX   PubMed=2668275;
RA   Stein C., Hille A., Seidel J., Rijnbout S., Waheed A., Schmidt B.,
RA   Geuze H., von Figura K.;
RT   "Cloning and expression of human steroid-sulfatase. Membrane topology,
RT   glycosylation, and subcellular distribution in BHK-21 cells.";
RL   J. Biol. Chem. 264:13865-13872(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=3032454; DOI=10.1016/0092-8674(87)90447-8;
RA   Yen P.H., Allen E., Marsh B., Mohandas T., Wang N., Taggart R.T.,
RA   Shapiro L.J.;
RT   "Cloning and expression of steroid sulfatase cDNA and the frequent
RT   occurrence of deletions in STS deficiency: implications for X-Y
RT   interchange.";
RL   Cell 49:443-454(1987).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 134-174 AND 461-583.
RX   PubMed=3203382; DOI=10.1016/0092-8674(88)90257-7;
RA   Yen P.H., Marsh B., Allen E., Tsai S.P., Ellison J., Connolly L.,
RA   Neiswanger K., Shapiro L.J.;
RT   "The human X-linked steroid sulfatase gene and a Y-encoded pseudogene:
RT   evidence for an inversion of the Y chromosome during primate
RT   evolution.";
RL   Cell 55:1123-1135(1988).
RN   [6]
RP   PROTEIN SEQUENCE OF 22-45.
RC   TISSUE=Liver;
RX   PubMed=2765556; DOI=10.1016/0167-4838(89)90187-8;
RA   Kawano J., Kotani T., Ohtaki S., Minamino N., Matsuo H., Oinuma T.,
RA   Aikawa E.;
RT   "Characterization of rat and human steroid sulfatases.";
RL   Biochim. Biophys. Acta 997:199-205(1989).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) IN COMPLEX WITH CALCIUM IONS,
RP   COFACTOR, OXOALANINE AT CYS-75, TRANSMEMBRANE TOPOLOGY, ACTIVE SITE,
RP   AND GLYCOSYLATION AT ASN-47 AND ASN-259.
RX   PubMed=12657638; DOI=10.1074/jbc.M211497200;
RA   Hernandez-Guzman F.G., Higashiyama T., Pangborn W., Osawa Y.,
RA   Ghosh D.;
RT   "Structure of human estrone sulfatase suggests functional roles of
RT   membrane association.";
RL   J. Biol. Chem. 278:22989-22997(2003).
RN   [8]
RP   VARIANTS IXL LEU-341; ARG-372 AND TYR-446.
RX   PubMed=1539590;
RA   Basler E., Grompe M., Parenti G., Yates J., Ballabio A.;
RT   "Identification of point mutations in the steroid sulfatase gene of
RT   three patients with X-linked ichthyosis.";
RL   Am. J. Hum. Genet. 50:483-491(1992).
RN   [9]
RP   VARIANTS IXL LEU-341; ARG-372; SER-372; ARG-444 AND TYR-446.
RX   PubMed=9252398; DOI=10.1074/jbc.272.33.20756;
RA   Alperin E.S., Shapiro L.J.;
RT   "Characterization of point mutations in patients with X-linked
RT   ichthyosis. Effects on the structure and function of the steroid
RT   sulfatase protein.";
RL   J. Biol. Chem. 272:20756-20763(1997).
RN   [10]
RP   VARIANT IXL PRO-560.
RX   PubMed=10679952;
RX   DOI=10.1002/(SICI)1098-1004(200003)15:3<296::AID-HUMU17>3.0.CO;2-#;
RA   Sugawara T., Shimizu H., Hoshi N., Fujimoto Y., Nakajima A.,
RA   Fujimoto S.;
RT   "PCR diagnosis of X-linked ichthyosis: identification of a novel
RT   mutation (E560P) of the steroid sulfatase gene.";
RL   Hum. Mutat. 15:296-296(2000).
RN   [11]
RP   VARIANT IXL ARG-380.
RX   PubMed=10844566; DOI=10.1046/j.1523-1747.2000.00004.x;
RA   Oyama N., Satoh M., Iwatsuki K., Kaneko F.;
RT   "Novel point mutations in the steroid sulfatase gene in patients with
RT   X-linked ichthyosis: transfection analysis using the mutated genes.";
RL   J. Invest. Dermatol. 114:1195-1199(2000).
CC   -!- FUNCTION: Conversion of sulfated steroid precursors to estrogens
CC       during pregnancy.
CC   -!- CATALYTIC ACTIVITY: 3-beta-hydroxyandrost-5-en-17-one 3-sulfate +
CC       H(2)O = 3-beta-hydroxyandrost-5-en-17-one + sulfate.
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC         Evidence={ECO:0000269|PubMed:12657638};
CC       Note=Binds 1 Ca(2+) ion per subunit.
CC       {ECO:0000269|PubMed:12657638};
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:12657638}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Multi-pass
CC       membrane protein.
CC   -!- PTM: The conversion to 3-oxoalanine (also known as C-
CC       formylglycine, FGly), of a serine or cysteine residue in
CC       prokaryotes and of a cysteine residue in eukaryotes, is critical
CC       for catalytic activity. {ECO:0000269|PubMed:12657638}.
CC   -!- DISEASE: Ichthyosis, X-linked (IXL) [MIM:308100]: A keratinization
CC       disorder manifesting with mild erythroderma and generalized
CC       exfoliation of the skin within a few weeks after birth. Affected
CC       boys later develop large, polygonal, dark brown scales, especially
CC       on the neck, extremities, trunk, and buttocks.
CC       {ECO:0000269|PubMed:10679952, ECO:0000269|PubMed:10844566,
CC       ECO:0000269|PubMed:1539590, ECO:0000269|PubMed:9252398}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- SIMILARITY: Belongs to the sulfatase family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Steroid sulfatase entry;
CC       URL="https://en.wikipedia.org/wiki/Steroid_sulfatase";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; J04964; AAA60597.1; -; mRNA.
DR   EMBL; M16505; AAA60596.1; -; mRNA.
DR   EMBL; AK314034; BAG36744.1; -; mRNA.
DR   EMBL; BC075030; AAH75030.1; -; mRNA.
DR   EMBL; M23945; AAA60598.1; -; Genomic_DNA.
DR   EMBL; M23556; AAA60599.1; -; Genomic_DNA.
DR   CCDS; CCDS14127.1; -.
DR   PIR; A32641; KJHUAC.
DR   RefSeq; NP_000342.2; NM_000351.5.
DR   RefSeq; NP_001307679.1; NM_001320750.1.
DR   RefSeq; NP_001307680.1; NM_001320751.1.
DR   RefSeq; NP_001307681.1; NM_001320752.1.
DR   RefSeq; NP_001307682.1; NM_001320753.1.
DR   RefSeq; NP_001307683.1; NM_001320754.1.
DR   UniGene; Hs.522578; -.
DR   UniGene; Hs.700558; -.
DR   UniGene; Hs.700559; -.
DR   UniGene; Hs.740067; -.
DR   PDB; 1P49; X-ray; 2.60 A; A=22-583.
DR   PDBsum; 1P49; -.
DR   ProteinModelPortal; P08842; -.
DR   SMR; P08842; -.
DR   BioGrid; 106905; 21.
DR   IntAct; P08842; 1.
DR   MINT; MINT-1177440; -.
DR   STRING; 9606.ENSP00000217961; -.
DR   BindingDB; P08842; -.
DR   ChEMBL; CHEMBL3559; -.
DR   DrugBank; DB02735; 2-Amino-3-Oxo-4-Sulfo-Butyric Acid.
DR   DrugBank; DB06713; Norelgestromin.
DR   SwissLipids; SLP:000001236; -.
DR   iPTMnet; P08842; -.
DR   PhosphoSitePlus; P08842; -.
DR   SwissPalm; P08842; -.
DR   BioMuta; STS; -.
DR   DMDM; 135006; -.
DR   EPD; P08842; -.
DR   MaxQB; P08842; -.
DR   PaxDb; P08842; -.
DR   PeptideAtlas; P08842; -.
DR   PRIDE; P08842; -.
DR   Ensembl; ENST00000217961; ENSP00000217961; ENSG00000101846.
DR   GeneID; 412; -.
DR   KEGG; hsa:412; -.
DR   UCSC; uc004cry.5; human.
DR   CTD; 412; -.
DR   DisGeNET; 412; -.
DR   GeneCards; STS; -.
DR   HGNC; HGNC:11425; STS.
DR   HPA; HPA002904; -.
DR   MalaCards; STS; -.
DR   MIM; 300747; gene.
DR   MIM; 308100; phenotype.
DR   neXtProt; NX_P08842; -.
DR   OpenTargets; ENSG00000101846; -.
DR   Orphanet; 461; Recessive X-linked ichthyosis.
DR   Orphanet; 281090; Syndromic X-linked ichthyosis.
DR   PharmGKB; PA36225; -.
DR   eggNOG; KOG3867; Eukaryota.
DR   eggNOG; COG3119; LUCA.
DR   GeneTree; ENSGT00760000119062; -.
DR   HOGENOM; HOG000135352; -.
DR   HOVERGEN; HBG004283; -.
DR   InParanoid; P08842; -.
DR   KO; K01131; -.
DR   OMA; WPRVIQA; -.
DR   OrthoDB; EOG091G07AL; -.
DR   PhylomeDB; P08842; -.
DR   TreeFam; TF314186; -.
DR   BRENDA; 3.1.6.2; 2681.
DR   Reactome; R-HSA-1660662; Glycosphingolipid metabolism.
DR   Reactome; R-HSA-1663150; The activation of arylsulfatases.
DR   ChiTaRS; STS; human.
DR   EvolutionaryTrace; P08842; -.
DR   GeneWiki; Steroid_sulfatase; -.
DR   GenomeRNAi; 412; -.
DR   PRO; PR:P08842; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000101846; -.
DR   CleanEx; HS_STS; -.
DR   Genevisible; P08842; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; TAS:ProtInc.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; TAS:Reactome.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0005768; C:endosome; TAS:ProtInc.
DR   GO; GO:0005794; C:Golgi apparatus; TAS:ProtInc.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; TAS:ProtInc.
DR   GO; GO:0005764; C:lysosome; TAS:ProtInc.
DR   GO; GO:0016020; C:membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; TAS:ProtInc.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004773; F:steryl-sulfatase activity; TAS:Reactome.
DR   GO; GO:0008484; F:sulfuric ester hydrolase activity; IDA:MGI.
DR   GO; GO:0008544; P:epidermis development; TAS:ProtInc.
DR   GO; GO:0007565; P:female pregnancy; IEA:UniProtKB-KW.
DR   GO; GO:0006687; P:glycosphingolipid metabolic process; TAS:Reactome.
DR   GO; GO:0043687; P:post-translational protein modification; TAS:Reactome.
DR   GO; GO:0006706; P:steroid catabolic process; TAS:ProtInc.
DR   Gene3D; 3.40.720.10; -; 1.
DR   InterPro; IPR017849; Alkaline_Pase-like_a/b/a.
DR   InterPro; IPR017850; Alkaline_phosphatase_core.
DR   InterPro; IPR024607; Sulfatase_CS.
DR   InterPro; IPR000917; Sulfatase_N.
DR   Pfam; PF00884; Sulfatase; 1.
DR   SUPFAM; SSF53649; SSF53649; 1.
DR   PROSITE; PS00523; SULFATASE_1; 1.
DR   PROSITE; PS00149; SULFATASE_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Calcium; Complete proteome; Direct protein sequencing;
KW   Disease mutation; Disulfide bond; Endoplasmic reticulum; Glycoprotein;
KW   Hydrolase; Ichthyosis; Lipid metabolism; Membrane; Metal-binding;
KW   Pregnancy; Reference proteome; Signal; Steroid metabolism;
KW   Transmembrane; Transmembrane helix.
FT   SIGNAL        1     21       {ECO:0000269|PubMed:2765556}.
FT   CHAIN        22    583       Steryl-sulfatase.
FT                                /FTId=PRO_0000033414.
FT   TOPO_DOM     22    184       Lumenal.
FT   TRANSMEM    185    208       Helical.
FT   TOPO_DOM    209    212       Cytoplasmic.
FT   TRANSMEM    213    234       Helical.
FT   TOPO_DOM    235    583       Lumenal.
FT   ACT_SITE    136    136       {ECO:0000269|PubMed:12657638}.
FT   METAL        35     35       Calcium. {ECO:0000269|PubMed:12657638}.
FT   METAL        36     36       Calcium. {ECO:0000269|PubMed:12657638}.
FT   METAL        75     75       Calcium; via 3-oxoalanine.
FT                                {ECO:0000269|PubMed:12657638}.
FT   METAL       342    342       Calcium. {ECO:0000269|PubMed:12657638}.
FT   METAL       343    343       Calcium. {ECO:0000269|PubMed:12657638}.
FT   SITE        333    333       Not glycosylated.
FT                                {ECO:0000269|PubMed:2668275}.
FT   SITE        459    459       Not glycosylated.
FT                                {ECO:0000269|PubMed:2668275}.
FT   MOD_RES      75     75       3-oxoalanine (Cys).
FT                                {ECO:0000269|PubMed:12657638}.
FT   CARBOHYD     47     47       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:12657638,
FT                                ECO:0000269|PubMed:2668275}.
FT   CARBOHYD    259    259       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:12657638,
FT                                ECO:0000269|PubMed:2668275}.
FT   DISULFID    141    148
FT   DISULFID    170    242
FT   DISULFID    446    489
FT   DISULFID    481    487
FT   DISULFID    562    570
FT   DISULFID    563    572
FT   VARIANT     341    341       S -> L (in IXL; loss of activity;
FT                                dbSNP:rs137853167).
FT                                {ECO:0000269|PubMed:1539590,
FT                                ECO:0000269|PubMed:9252398}.
FT                                /FTId=VAR_007240.
FT   VARIANT     372    372       W -> R (in IXL; loss of activity;
FT                                dbSNP:rs137853165).
FT                                {ECO:0000269|PubMed:1539590,
FT                                ECO:0000269|PubMed:9252398}.
FT                                /FTId=VAR_007241.
FT   VARIANT     372    372       W -> S (in IXL; loss of activity;
FT                                dbSNP:rs137853168).
FT                                {ECO:0000269|PubMed:9252398}.
FT                                /FTId=VAR_014020.
FT   VARIANT     380    380       G -> R (in IXL).
FT                                {ECO:0000269|PubMed:10844566}.
FT                                /FTId=VAR_014021.
FT   VARIANT     444    444       H -> R (in IXL; loss of activity;
FT                                dbSNP:rs137853169).
FT                                {ECO:0000269|PubMed:9252398}.
FT                                /FTId=VAR_014022.
FT   VARIANT     446    446       C -> Y (in IXL; loss of activity;
FT                                dbSNP:rs137853166).
FT                                {ECO:0000269|PubMed:1539590,
FT                                ECO:0000269|PubMed:9252398}.
FT                                /FTId=VAR_007242.
FT   VARIANT     560    560       Q -> P (in IXL).
FT                                {ECO:0000269|PubMed:10679952}.
FT                                /FTId=VAR_014023.
FT   CONFLICT     23     23       A -> E (in Ref. 2; AAA60596).
FT                                {ECO:0000305}.
FT   STRAND       28     36       {ECO:0000244|PDB:1P49}.
FT   HELIX        43     45       {ECO:0000244|PDB:1P49}.
FT   STRAND       48     50       {ECO:0000244|PDB:1P49}.
FT   HELIX        53     56       {ECO:0000244|PDB:1P49}.
FT   TURN         57     61       {ECO:0000244|PDB:1P49}.
FT   STRAND       62     69       {ECO:0000244|PDB:1P49}.
FT   HELIX        75     84       {ECO:0000244|PDB:1P49}.
FT   HELIX        88     91       {ECO:0000244|PDB:1P49}.
FT   STRAND       96     98       {ECO:0000244|PDB:1P49}.
FT   HELIX       118    124       {ECO:0000244|PDB:1P49}.
FT   STRAND      128    134       {ECO:0000244|PDB:1P49}.
FT   STRAND      141    143       {ECO:0000244|PDB:1P49}.
FT   TURN        144    146       {ECO:0000244|PDB:1P49}.
FT   HELIX       151    153       {ECO:0000244|PDB:1P49}.
FT   STRAND      157    164       {ECO:0000244|PDB:1P49}.
FT   HELIX       168    170       {ECO:0000244|PDB:1P49}.
FT   HELIX       179    185       {ECO:0000244|PDB:1P49}.
FT   HELIX       187    205       {ECO:0000244|PDB:1P49}.
FT   HELIX       213    241       {ECO:0000244|PDB:1P49}.
FT   STRAND      244    246       {ECO:0000244|PDB:1P49}.
FT   STRAND      249    254       {ECO:0000244|PDB:1P49}.
FT   HELIX       260    273       {ECO:0000244|PDB:1P49}.
FT   TURN        274    277       {ECO:0000244|PDB:1P49}.
FT   STRAND      280    285       {ECO:0000244|PDB:1P49}.
FT   STRAND      290    292       {ECO:0000244|PDB:1P49}.
FT   TURN        297    299       {ECO:0000244|PDB:1P49}.
FT   STRAND      304    306       {ECO:0000244|PDB:1P49}.
FT   HELIX       307    328       {ECO:0000244|PDB:1P49}.
FT   HELIX       332    334       {ECO:0000244|PDB:1P49}.
FT   STRAND      335    343       {ECO:0000244|PDB:1P49}.
FT   STRAND      352    354       {ECO:0000244|PDB:1P49}.
FT   STRAND      370    372       {ECO:0000244|PDB:1P49}.
FT   HELIX       373    376       {ECO:0000244|PDB:1P49}.
FT   STRAND      380    383       {ECO:0000244|PDB:1P49}.
FT   TURN        385    387       {ECO:0000244|PDB:1P49}.
FT   HELIX       400    402       {ECO:0000244|PDB:1P49}.
FT   HELIX       403    411       {ECO:0000244|PDB:1P49}.
FT   STRAND      417    419       {ECO:0000244|PDB:1P49}.
FT   HELIX       427    430       {ECO:0000244|PDB:1P49}.
FT   STRAND      440    446       {ECO:0000244|PDB:1P49}.
FT   STRAND      449    455       {ECO:0000244|PDB:1P49}.
FT   STRAND      464    468       {ECO:0000244|PDB:1P49}.
FT   TURN        482    484       {ECO:0000244|PDB:1P49}.
FT   STRAND      489    491       {ECO:0000244|PDB:1P49}.
FT   STRAND      501    503       {ECO:0000244|PDB:1P49}.
FT   TURN        505    507       {ECO:0000244|PDB:1P49}.
FT   TURN        518    521       {ECO:0000244|PDB:1P49}.
FT   HELIX       523    537       {ECO:0000244|PDB:1P49}.
FT   HELIX       550    553       {ECO:0000244|PDB:1P49}.
FT   HELIX       557    559       {ECO:0000244|PDB:1P49}.
FT   STRAND      563    568       {ECO:0000244|PDB:1P49}.
SQ   SEQUENCE   583 AA;  65492 MW;  74746AFA9D21A0A6 CRC64;
     MPLRKMKIPF LLLFFLWEAE SHAASRPNII LVMADDLGIG DPGCYGNKTI RTPNIDRLAS
     GGVKLTQHLA ASPLCTPSRA AFMTGRYPVR SGMASWSRTG VFLFTASSGG LPTDEITFAK
     LLKDQGYSTA LIGKWHLGMS CHSKTDFCHH PLHHGFNYFY GISLTNLRDC KPGEGSVFTT
     GFKRLVFLPL QIVGVTLLTL AALNCLGLLH VPLGVFFSLL FLAALILTLF LGFLHYFRPL
     NCFMMRNYEI IQQPMSYDNL TQRLTVEAAQ FIQRNTETPF LLVLSYLHVH TALFSSKDFA
     GKSQHGVYGD AVEEMDWSVG QILNLLDELR LANDTLIYFT SDQGAHVEEV SSKGEIHGGS
     NGIYKGGKAN NWEGGIRVPG ILRWPRVIQA GQKIDEPTSN MDIFPTVAKL AGAPLPEDRI
     IDGRDLMPLL EGKSQRSDHE FLFHYCNAYL NAVRWHPQNS TSIWKAFFFT PNFNPVGSNG
     CFATHVCFCF GSYVTHHDPP LLFDISKDPR ERNPLTPASE PRFYEILKVM QEAADRHTQT
     LPEVPDQFSW NNFLWKPWLQ LCCPSTGLSC QCDREKQDKR LSR
//
